Načítá se...
Tamoxifen regulation of sphingolipid metabolism—therapeutic implications
Tamoxifen, a triphenylethylene antiestrogen and one of the first-line endocrine therapies used to treat estrogen receptor-positive breast cancer, has a number of interesting, off-target effects, and among these is the inhibition of sphingolipid metabolism. More specifically, tamoxifen inhibits ceram...
Uloženo v:
| Vydáno v: | Biochim Biophys Acta |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4516673/ https://ncbi.nlm.nih.gov/pubmed/25964209 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbalip.2015.05.001 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|